000 | 01331 a2200325 4500 | ||
---|---|---|---|
005 | 20250516134424.0 | ||
264 | 0 | _c20140826 | |
008 | 201408s 0 0 eng d | ||
022 | _a1875-5402 | ||
024 | 7 |
_a10.2174/1386207311316060002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPrakash, Om | |
245 | 0 | 0 |
_aDevelopment of method for three-point data estimation and SVR-QSAR model to screen anti cancer leads. _h[electronic resource] |
260 |
_bCombinatorial chemistry & high throughput screening _cJul 2013 |
||
300 |
_a425-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aGossypol _xanalogs & derivatives |
650 | 0 | 4 |
_aHigh-Throughput Screening Assays _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
650 | 0 | 4 | _aQuantitative Structure-Activity Relationship |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aSupport Vector Machine |
700 | 1 | _aKhan, Feroz | |
773 | 0 |
_tCombinatorial chemistry & high throughput screening _gvol. 16 _gno. 6 _gp. 425-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1386207311316060002 _zAvailable from publisher's website |
999 |
_c22504877 _d22504877 |